Hosted on MSN1mon
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The US Food and Drug Administration (FDA) has granted fast track designation for the development of Bracco Imaging's molecular imaging ultrasound contrast agent, BR55, to identify active bowel ...
Yahoo Finance1mon
FDA fast tracks Bracco’s BR55 for Crohn’s disease bowel inflammation detection
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit ...